A notable example is phosphomannomutase 2 (PMM2)-CDG (MIM: 212065), the most common CDG, with an estimated incidence of 1:20,000 people, and the first ever described CDG in 1980 (128, 129). Here, PMM2 is linked to congenital disorder of glycosylation.